6-KThe Wire

Alpha Tau Medical Ltd. files 6-K

Filed May 11, 2026 · 2mo ago · Accession 0001213900-26-054252

Plain English

Alpha Tau Medical Ltd. presented interim clinical data from its U.S. trial of Alpha DaRT for patients with recurrent glioblastoma (GBM) during a conference call and webcast on May 11, 2026. The presentation, containing this data, was also made available on the Company's website.

Read the original on SEC.gov ↗

Filing details

Company: Alpha Tau Medical Ltd.
Ticker: DRTS
CIK: 1871321
Form type: 6-K
Filing date: May 11, 2026
Report date: May 11, 2026
Document: ea0290058-6k_alpha.htm
Size: 29.9 MB

More from DRTS

6-KREPORT OF FOREIGN PRIVATE ISSUERJul 21, 2026 6-KREPORT OF FOREIGN PRIVATE ISSUERJun 25, 2026 6-KREPORT OF FOREIGN PRIVATE ISSUERJun 23, 2026 6-KREPORT OF FOREIGN PRIVATE ISSUERJun 11, 2026 6-KREPORT OF FOREIGN PRIVATE ISSUERJun 3, 2026 6-KREPORT OF FOREIGN PRIVATE ISSUERJun 1, 2026